| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of DBC1 mRNA | affects expression | 16483693
|
| C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of DBC1 mRNA | increases expression | 15761015
|
| D019324 |
beta-Naphthoflavone |
beta-Naphthoflavone results in increased expression of DBC1 mRNA | increases expression | 19737606
|
| D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of DBC1 mRNA | decreases expression | 20106945
|
| C014347 |
decitabine |
[decitabine co-treated with trichostatin A] inhibits the reaction [sodium arsenite affects the methylation of DBC1 promoter] | affects cotreatment|affects methylation|decreases reaction | 18448484
|
| C014347 |
decitabine |
decitabine inhibits the reaction [sodium arsenite affects the methylation of DBC1 promoter] | affects methylation|decreases reaction | 18448484
|
| D005419 |
Flavonoids |
Flavonoids results in decreased expression of DBC1 mRNA | decreases expression | 18035473
|
| C406082 |
monomethylarsonous acid |
[monomethylarsonous acid affects the acetylation of HIST3H3 protein] which affects the methylation of DBC1 promoter | affects acetylation|affects methylation | 18448484
|
| C406082 |
monomethylarsonous acid |
monomethylarsonous acid results in decreased expression of DBC1 mRNA | decreases expression | 20375083
|
| C017947 |
sodium arsenite |
[decitabine co-treated with trichostatin A] inhibits the reaction [sodium arsenite affects the methylation of DBC1 promoter] | affects cotreatment|affects methylation|decreases reaction | 18448484
|
| C017947 |
sodium arsenite |
decitabine inhibits the reaction [sodium arsenite affects the methylation of DBC1 promoter] | affects methylation|decreases reaction | 18448484
|
| C017947 |
sodium arsenite |
[sodium arsenite affects the acetylation of HIST3H3 protein] which affects the methylation of DBC1 promoter | affects acetylation|affects methylation | 18448484
|
| C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of DBC1 mRNA | decreases expression | 18448484
|
| C012589 |
trichostatin A |
[decitabine co-treated with trichostatin A] inhibits the reaction [sodium arsenite affects the methylation of DBC1 promoter] | affects cotreatment|affects methylation|decreases reaction | 18448484
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.84 | 18287403 |
| MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
2.33 | 11798837 19825857 |
| MESH:D000236 |
Adenoma |
|
beta-Naphthoflavone |
3.44 | 19389873 |
| MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
5.02 | 15276417 |
| MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.22 | 17306315 16712894 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
3.88 | 16206674 |
| MESH:D001943 |
Breast Neoplasms |
|
decitabine |
2.55 | 19208741 18320071 |
| MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.55 | 11589617 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
3.19 | 11135700 16217749 15073043 14691202 15553829 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
3.19 | 15276417 17306315 16507464 |
| MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
5.19 | 19014326 |
| MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.31 | 12490120 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
4.97 | 19215824 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
4.97 | 18572023 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
12.14 | 12371664 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
monomethylarsonous acid |
12.14 | 19716837 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
12.14 | 20056578 19524636 |
| MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.06 | 19486331 |
| MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.36 | 17616700 |
| MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
2.62 | 20501625 |
| MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.62 | 18981723 |
| MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.42 | 12609071 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
1.89 | 10525206 |
| MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
4.32 | 15213294 |
| MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
15.11 | 19294695 |
| MESH:D004701 |
Endocrine Gland Neoplasms |
|
trichostatin A |
15.11 | 19294695 |
| MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
2.35 | 12903497 |
| MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
8.45 | 15073043 |
| MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
8.45 | 19224547 |
| MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.40 | 12639820 12168785 |
| MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.50 | 16904648 |
| MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.96 | 16452187 |
| MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.50 | 8708960 |
| MESH:D005909 |
Glioblastoma |
|
trichostatin A |
3.96 | 18801729 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.62 | 19215824 |
| MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.71 | 15720958 |
| MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.33 | 12676792 |
| MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.16 | 10903974 |
| MESH:D007248 |
Infertility, Male |
|
decitabine |
7.35 | 17581917 |
| MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
7.35 | 15346721 12646999 |
| MESH:D007249 |
Inflammation |
|
Flavonoids |
2.74 | 17296493 |
| MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.76 | 15604871 |
| MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.38 | 18776723 10903974 8314463 |
| MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
6.38 | 20008137 |
| MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.90 | 12371664 |
| MESH:D007938 |
Leukemia |
|
arsenic trioxide |
6.76 | 15070760 |
| MESH:D007938 |
Leukemia |
|
decitabine |
6.76 | 18980019 19235587 |
| MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
4.00 | 12560223 17077332 |
| MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.59 | 16972261 |
| MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.58 | 14633726 |
| MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
10.28 | 19077051 |
| MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
10.28 | 19117987 17236224 18454857 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
6.46 | 16968895 17050201 16467208 20471514 19850784 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
6.46 | 17679729 18460780 19010910 18206229 19387464 18704418 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
trichostatin A |
6.46 | 18206229 |
| MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.78 | 18055864 |
| MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
3.34 | 9834237 19075265 17712046 17869043 19035177 15622746 12712474 12679006 17649720 15213294 16823087 15748426 19642359 11161223 16891316 16966277 17107899 16330433 17217047 16112521 12018890 16331271 19225113 15336539 11468182 |
| MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.59 | 16882451 |
| MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
7.96 | 14682389 |
| MESH:D008113 |
Liver Neoplasms |
|
beta-Naphthoflavone |
7.96 | 19389873 21295105 |
| MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
7.96 | 15276417 16712894 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
6.58 | 20377131 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta-Naphthoflavone |
6.58 | 18164116 |
| MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.51 | 15213294 |
| MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.30 | 19095001 |
| MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
2.58 | 11798837 19825857 |
| MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
2.58 | 15276417 17306315 16712894 17077188 19931552 |
| MESH:D008223 |
Lymphoma |
|
decitabine |
3.56 | 19470736 |
| MESH:D008545 |
Melanoma |
|
decitabine |
5.44 | 16505122 17785578 |
| MESH:D008545 |
Melanoma |
|
sodium arsenite |
5.44 | 16487513 19082730 |
| MESH:D008545 |
Melanoma |
|
trichostatin A |
5.44 | 16505122 |
| MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.11 | 16801185 |
| MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
13.08 | 14977855 19417148 19549372 15949261 11468182 |
| MESH:D009101 |
Multiple Myeloma |
|
decitabine |
13.08 | 18172295 |
| MESH:D009101 |
Multiple Myeloma |
|
trichostatin A |
13.08 | 18172295 |
| MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.99 | 18349030 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
7.86 | 16882451 16105982 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
7.86 | 19157545 16882708 19010910 18608210 |
| MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
4.20 | 16624393 |
| MESH:D009369 |
Neoplasms |
|
decitabine |
5.53 | 17925555 19116145 19470736 |
| MESH:D009369 |
Neoplasms |
|
sodium arsenite |
5.53 | 11559025 |
| MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.92 | 20056578 |
| MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.76 | 17954296 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.47 | 19348381 18481113 |
| MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
7.76 | 10525206 |
| MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
7.76 | 12854658 |
| MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
11.82 | 12452020 16624393 19769630 |
| MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
11.82 | 19259094 19331143 |
| MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
11.82 | 17306315 15276417 |
| MESH:D010051 |
Ovarian Neoplasms |
|
trichostatin A |
11.82 | 19331143 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
9.15 | 15580305 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
9.15 | 19294695 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
trichostatin A |
9.15 | 19294695 |
| MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.38 | 19927285 |
| MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.40 | 12371664 |
| MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
13.31 | 17616702 |
| MESH:D055728 |
Primary Myelofibrosis |
|
trichostatin A |
13.31 | 17616702 |
| MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.66 | 19131511 |
| MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.66 | 16039940 |
| MESH:D011471 |
Prostatic Neoplasms |
|
trichostatin A |
2.66 | 18798265 19789329 |
| MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.29 | 16882103 |
| MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.62 | 19155313 |
| MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
4.20 | 16646077 |
| MESH:D012871 |
Skin Diseases |
|
monomethylarsonous acid |
3.42 | 17431481 |
| MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
2.78 | 18572023 19524636 |
| MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.95 | 12854658 |
| MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
2.61 | 17007042 |
| MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.61 | 19037991 |
| MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
7.84 | 19014326 |
| MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
7.84 | 17967635 |
| MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
4.24 | 15213294 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
12.60 | 12973940 11780464 12845720 20435036 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
12.60 | 17616700 19087683 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
monomethylarsonous acid |
12.60 | 20375083 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
12.60 | 16712894 16452187 17306315 11723127 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.96 | 11813266 |
| MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
5.23 | 17785578 |
| MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.30 | 1336536 |
| MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.71 | 17056641 |
| MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.76 | 17120751 |